B. Braun is a medical technology and healthcare solutions company founded in 1839 in Melsungen, Germany. With annual sales of approximately €9.4 billion and more than 64,000 employees across operations on every continent, the company operates across medical devices, pharmaceuticals, clinical nutrition, renal care, and surgical instruments. The company remains under family stewardship in its sixth generation of ownership.
The company's product portfolio spans infusion equipment, dialysis machines, clinical nutrition products, and surgical innovations. B. Braun developed the Braunüle in the 1950s, a single-use plastic infusion device that established the company in a new product category. The company introduced Lipofundin, a clinical nutrition product, in 1962. Through its Aesculap division, B. Braun produces surgical instruments and innovations.
B. Braun's operations encompass pharmaceutical production, extracorporeal blood treatment systems, and integrated healthcare solutions. The company's founding principle centres on protecting and improving the health of people globally, reflecting its origins in a community pharmacy that expanded into a multinational medical technology manufacturer.
